Interaction of macrolides and ketolides with the phagocytic cell line PLB-985

Journal of Chemotherapy

Volumn 15, Issue 4, 2003, Pages 350-356

  Abdelghaffar, H ^a   Soukri, A ^a   Babin Chevaye, C ^b   Labro, Marie Thérèse ^b  

^a HASSAN II UNIVERSITY   (Morocco)

^b BICHAT HOSPITAL   (France)

Author keywords

Ketolide; Macrolide; PLB 985; Polymorphonuclear neutrophils

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CARBON 14; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HMR 3004; HMR 3562; HMR 3787; KETOLIDE; MACROLIDE; PHORBOL 13 ACETATE 12 MYRISTATE; ROXITHROMYCIN; SUPEROXIDE; TELITHROMYCIN; TRITIUM; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CELL MEMBRANE; DRUG UPTAKE; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOMODULATION; ISOTOPE LABELING; NEUTROPHIL; PHAGOCYTE; RADIOACTIVITY;

EID: 0042347828     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2003.15.4.350     Document Type: Article

References (21)

1. Hellewell PG, Williams TJ. (Eds) Immunopharmacology of neutrophils. Academic Press. London, San Diego, New York, 1994.
2. Van den Broek PJ. Antimicrobial drugs, microorganisms, and phagocytes. Rev Infect Dis 1989; 11: 213-45.
3. Labro MT. Interference of antibacterial agents with phagocyte functions: immunomodulation or «immuno-fairy» tales. Clin Microbiol Rev 2000; 13: 615-650.
4. Labro MT. Antiinflammatory activity of macrolides. A new therapeutic potential? J Antimicrob Chemother 1998; 41 (Suppl. B): 39-46.
5. Labro MT. Immunological effects of macrolides. Curr Op Infect Dis 1998; 11: 681-688.
6. Labro MT, El Benna J, Babin-Chevaye C. Comparison of the in vitro effect of several macrolides on the oxidative burst of human neutrophils. J Antimicrob Chemother 1989; 24: 561-572.
7. Abdelghaffar H, Vazifeh D, Labro MT. Erythromycin A-derived macrolides modify the functional activities of human neutrophils by altering the phospholipase D-phosphatidate phosphohydrolase transduction pathway. J Immunol 1997; 159: 3995-4005.
8. Anderson R. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-derived superoxide generation and auto-oxidation. J Infect Dis 1989; 159: 966-973.
9. Laufen H, Wildfeuer A, Lach P. Mechanism of azithromycin uptake in human leucocytes. Arzneim Forschung 1990; 40: 686-689.
10. Vazifeh D, Abdelghaffar H, Labro MT. Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin. Antimicrob Agents Chemother 1997; 41: 2099-2107.
11. Vazifeh D, Preira A, Bryskier A, Labro MT. Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils. Antimicrob Agents Chemother 1998; 42: 1944-1951.
12. Labro MT, El Benna J, Abdelghaffar H. Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin. J Antimicrob Chemother 1993; 31 (Suppl. C): 51-64.
13. Tucker KA, Lilly MB, Heck L, Rado TA. Characterization of a new human diploid myeloid leukemia cell line (PLB-985) with granulocytic and monocytic differentiating capacity. Blood 1987; 70: 372-378.
14. Pedruzzi E, Fay M, Gaudry M, Gougerot-Pocidalo MA. Differentiation of PLB-985 myeloid cells into mature neutrophils, shown by degranulation of terminally differentiated compartments in response to N-formyl peptide and priming of superoxide anion production by granulocyte-macrophage colony-stimulating factor. Br J Haematol 2002; 117: 719-726.
15. Abdelghaffar H, Vazifeh D, Labro MT. Cellular uptake of two fluoroketolides, HMR 3562 and HMR 3787, by human polymorphonuclear neutrophils in vitro. Antimicrob Agents Chemother 2001; 45: 2798-2806.
16. Miossec-Bartoli C, Pilatre L, Peyron P, et al. The new ketolide HMR 3647 accumulates in the azurophilic granules of human polymorphonuclear cells. Antimicrob Agents Chemother 1999; 43: 2457-2462.
17. Vazifeh D, Bryskier A, Labro MT. Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647 or HMR 3004 and polymorphonuclear neutrophils. Antimicrob Agents Chemother 2000; 44: 511-521.
18. th ICAAC, September 26-29, San Francisco, ASM Press Washington DC, 1999 Abstr. 1929, p. 48.
19. Nibbering PH., Zomerdijk TP, Corsel-Van Tilburg AJ, Van Furth R. Mean cell volume of human blood leucocytes and resident and activated murine macrophages. Immunol Meth 1990; 129: 143-145.
20. Levert H, Gressier B, Moutard I et al. Azithromycin impact on neutrophil oxidative metabolism depends on exposure time. Inflammation 1998; 22: 191-201.
21. th ICAAC, September 15-18 New Orleans, ASM Press Washington DC, 1996 Abstr. F-225, p. 139.